Epstein-Barr virus associated graft failure following heart/lung transplantation.
- 1 November 1996
- Vol. 51 (11) , 1160-1165
- https://doi.org/10.1136/thx.51.11.1160
Abstract
A case is described of late pulmonary graft failure in a heart/lung transplant recipient. The major characteristics were alveolar fibrosis and a restrictive physiological deficit. Epstein-Barr virus was implicated as an aetiological agent using immunohistochemical analysis and by a response to treatment with ganciclovir.Keywords
This publication has 8 references indexed in Scilit:
- Detection of Epstein-Barr virus by polymerase chain reaction in transbronchial biopsies of lung transplant recipients: evidence of infection?1993
- Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimensHuman Pathology, 1993
- The pathology of heart and heart and lung transplantation--an update.Journal of Clinical Pathology, 1991
- Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantationThe Lancet, 1991
- A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation.1990
- Cytomegalovirus in the Lungs of Patients with AIDS: Respiratory Pathogen or Passenger?American Review of Respiratory Disease, 1990
- TWENTY-EIGHT CASES OF HUMAN HEART-LUNG TRANSPLANTATIONThe Lancet, 1986
- Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.Proceedings of the National Academy of Sciences, 1980